Periodic Reporting for period 1 - BCSC-ST (Breast cancer stem-like cells specific vulnerabilities: focus in HER2 over-expression and protein glycosylation)

New therapies for breast cancer are based on the molecular differences between cancerous and normal cells and have an increased efficiency and less secondary effects. Unfortunately, a significant number of tumours do not respond to the current treatments. A small population...